Publikationen von Verena Lohr

Lohr, V.; Hädicke, O.; Genzel, Y.; Jordan, I.; Buentemeyer, H.; Klamt, S.; Reichl, U.: The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnology 14, 72 (2014)

Hädicke, O.; Lohr, V.; Genzel, Y.; Reichl, U.; Klamt, S.: Evaluating differences of metabolic performances: Statistical methods and their application to animal cell cultivations. Biotechnology and Bioengineering 110 (10), S. 2633 - 2642 (2013)

Jordan, I.; Lohr, V.; Genzel, Y.; Reichl, U.; Sandig, V.: Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara. Microorganisms 1 (1), S. 100 - 121 (2013)

Lohr, V.; Genzel, Y.; Jordan, I.; Katinger, D.; Mahr, S.; Sandig, V.; Reichl, U.: Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnology 12, 79 (2012)

Petiot, E.; Jacob, D.; Lanthier, S.; Lohr, V.; Ansorge, S.; Kamen, A. A.: Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnology 11, 84 (2011)

Rödig, J.; Rapp, E.; Djeljadini, S.; Lohr, V.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Impact of Influenza Virus Adaptation Status on HA N-Glycosylation Patterns in Cell Culture-Based Vaccine Production. Journal of Carbohydrate Chemistry 30 (4-6), S. 281 - 290 (2011)

Lohr, V.; Genzel, Y.; Behrendt, I.; Scharfenberg, K.; Reichl, U.: A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28 (38), S. 6256 - 6264 (2010)

Lohr, V.; Rath, A.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine 27 (36), S. 4975 - 4982 (2009)

Lohr, V.; Rath, A.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Avian Designer Cells AGE1.CR as Candidates for MVA and Influenza Vaccine Production. In: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), S. 615 - 631 (Hg. Jenkins, N.; Barron, N.; Alves, P.). 21st ESACT Meeting, Dublin, Ireland, 07. Juni 2009 - 10. Juni 2009. (2012)

Genzel, Y.; Lohr, V.; Behrendt, I.; Scharfenberg, K.; Kamen, A.; Schiedner, G.; Jordan, I.; Reichl, U.: Cell culture-based influenza virus production: suspension or adherent producer cell lines? Cell line development and engineering 2012, Cologne, Germany (2012)

Genzel, Y.; Janke, R.; Isken, B.; Rödig, J.; Rapp, E.; Lohr, V.; Behrendt, I.; Scharfenberg, K.; Kamen, A.; Schiedner, G. et al.; Jordan, I.; Reichl, U.: Influenza virus production: characteristics of different producer cell lines. 10th PEACe 2011, Cascais, Portugal (2011)

Lohr, V.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Stoffwechsel und Zellphysiologie aviärer Designerzellen während Wachstum und MVA-Produktion. ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany (2009)

Lohr, V.; Rath, A.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Avian designer cells AGE1.CR: possible candidates for MVA and influenza vaccine production? 21st ESACT Meeting, Dublin, Ireland (2009)

Rath, A.; Lohr, V.; Genzel, Y.; Schwarzer, J.; Rapp, E.; Sandig, V.; Jordan, I.; Reichl, U.: Influenza and modified vaccinia Ankara (MVA) production in avian designer cells. Bioperspectives, Hannover, Germany (2008)

Tapia, F.; Vazquez-Ramirez, D.; Lohr, V.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: A flow cytometry-based assay for quantification of infectious influenza and vaccinia virions. Vaccine Technology 2014, Playa del Carmen, Mexico (2014)

von Stosch, M.; Vazquez-Ramirez, D.; Lohr, V.; de Azevedo, C.; Luis, M.; Genzel, Y.; Reichl, U.; Oliveira, R.: Towards effective media composition & process control optimization for high cell density cellbased virus production. ESBES - 10th European Symposium on Biochemical Engineering Sciences, Lille, France (2014)

Vázquez-Ramirez, D.; Lohr, V.; Díaz Mirón, J.E.Z.; Genzel, Y.; Reichl, U.: Development of a flow cytometry-based assay for the quantification of infectious influenza virions. 23rd ESACT Meeting , Lille, France (2013)

Lohr, V.; Blechert, A.-K.; Genzel, Y.; Jordan, I.; Reichl, U.: Characterization of AGE1.CR.pIX high cell density cultivations for vaccinia virus production. GVC/DECHEMA Vortrags- und Diskussionstagung Biopharmazeutische Produktion, Freiburg, Germany (2012)

Lohr, V.; Genzel, Y.; Katinger, D.; Jordan, I.; Sandig, V.; Reichl, U.: Live attenuated influenza virus production in batch high cell density cultivation of suspension AGE1.CR.pIX cells. Vaccine Technology IV, Albufeira, Portugal (2012)

Lohr, V.; Haedicke, O.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Comparative metabolic flux analyses of cultivations with novel avian designer cell lines used for vaccine production. Cell Culture Engineering XIII, Scottsdale, Arizona, USA (2012)